ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome

NCT04304482 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: ANAVEX2-73 oral liquid
DRUG: Placebo oral liquid

Sponsor

Anavex Life Sciences Corp.

Collaborators

[object Object]
[object Object]